Aeirtec

Aeirtec is a specialized service provider in the biomarker analysis space, focusing on overcoming the sensitivity limitations of standard immunoassays. Its core innovation is a patented technology platform that integrates unique biochemistry with advanced curve-fitting algorithms to accurately measure low-abundance, critical initiating mediators like cytokines. The company offers a modular suite of services, including multiplex immunoassays, targeted RNA-Seq, IHC, and flow cytometry, backed by decades of clinical protocol experience and biostatistical interpretation to support drug development efficacy and mechanism-of-action studies.

Patented ultrasensitive multiplex immunoassay technology combining proprietary biochemistry with advanced calibration curve analysis for quantification of protein markers in the low femtogram/ml range. Integrated service platform also includes targeted RNA-Seq for gene expression, multi-color fluorescence IHC, and flow cytometry.

Aeirtec competes in the biomarker analysis services market against large, full-service CROs (e.g., LabCorp, IQVIA) and specialized players offering high-plex or sensitive assays (e.g., Olink, SomaLogic, Meso Scale Discovery). Its differentiation is its claimed ultra-low femtogram/ml sensitivity for multiplex protein detection, a niche not fully addressed by standard offerings.